Dublin, March 31, 2026 (GLOBE NEWSWIRE) — The “Oncologists Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive statistics, including global market size, regional shares, and detailed market segments.
The global oncologists market has demonstrated consistent growth, anticipated to expand from $20.21 billion in 2025 to $21.09 billion in 2026 at a CAGR of 4.4%. This growth is driven by rising cancer incidences worldwide, increasing demand for specialized oncology care, the growth of hospital and clinic networks, advancements in diagnostic imaging technologies, and heightened awareness of early detection.
Looking forward, the market is poised to reach $25.07 billion by 2030, maintaining a 4.4% CAGR, fueled by innovations in personalized cancer therapies, digital oncology management, and technological advances in immunotherapy.
Key trends shaping the market include the adoption of AI and machine learning in cancer diagnosis, precision medicine, and genomic profiling. Additionally, automation in chemotherapy and IoT-enabled monitoring of oncology equipment are gaining traction. The increasing prevalence of cancer is a significant growth driver, with projections indicating a rise in cancer survivors in the US from 18.1 million in 2024 to 22.5 million by 2032. Annual new cancer cases are expected to reach 29.9 million by 2040.
Leading organizations are investing in AI-powered precision oncology centers to enhance personalized care and diagnostic accuracy. In January 2024, Apollo Cancer Centre in India launched an AI-enabled center, providing insights for timely interventions and comprehensive cancer risk assessments. Meanwhile, in July 2024, Mumbai Oncocare merged with Hemato Oncology Clinic to bolster its offerings through enhanced expertise.
Prominent companies in the market include Abramson Cancer Center, MD Anderson, Lilavati Hospital, Mount Elizabeth Hospital, Charite – Universitatsmedizin Berlin, Roche, Pfizer, Bayer, Merck, AbbVie, and others. North America led the market in 2025, with key regions being Asia-Pacific, Europe, Middle East, and Africa. Countries covered in research include the USA, China, India, Germany, UK, France, Canada, and Italy.
Reasons to Purchase:
- Obtain a global perspective with an all-inclusive report covering 16 geographies.
- Evaluate the impact of key macro factors such as geopolitical conflicts, trade policies, tariffs, inflation, interest rate fluctuations, and evolving regulatory landscapes.
- Formulate regional and country strategies using local data and analysis.
- Identify investment growth segments and outperform competitors using forecast data and the trends driving market evolution.
- Gain customer insights through end-user analysis and benchmark performance against key competitors focusing on market share, innovation, and brand strength.
- Analyze the total addressable market (TAM) and market attractiveness scoring to gauge potential.
- Access reliable, high-quality data and analysis, perfect for internal and external presentations.
- Receive timely updates and data delivered in an Excel datasheet for easy extraction and analysis, complemented by an Excel dashboard format.
Markets Covered: Cancer Diagnostics and Treatment, including Imaging Tests, Biopsy, Blood Tests, Molecular Diagnostics, Genetic Testing, and treatments like Chemotherapy, Radiation Therapy, Immunotherapy, and more.
Companies Mentioned: Notable organizations such as Abramson Cancer Center, MD Anderson Cancer Center, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., and several others.
Geographies and Regions: Analyzed areas include countries like Australia, Brazil, China, USA, and regions such as Asia-Pacific, North America, Middle East, among others.
Data and Format: Includes five years historic and ten years forecast time series, data segmentation, market share of competitors, and sourcing. Available in Word, PDF, or Interactive Report formats with Excel Dashboard.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2026-2030 |
| Estimated Market Value (USD) in 2026 | $21.09 Billion |
| Forecasted Market Value (USD) by 2030 | $25.07 Billion |
| Compound Annual Growth Rate | 4.4% |
| Regions Covered | Global |
The companies featured in this Oncologists market report include:
- Abramson Cancer Center
- MD Anderson Cancer Center of the University of Texas
- Lilavati Hospital & Research Centre
- Mount Elizabeth Hospital
- Mount Miriam Cancer Hospital
- Charite – Universitatsmedizin Berlin
- General Electric Healthcare
- F. Hoffmann-La Roche AG
- Pfizer Inc.
- Bayer AG
- Merck & Co. Inc.
- AbbVie Inc.
- Amgen Inc.
- Takeda Pharmaceuticals USA Inc.
- Becton Dickinson and Company
- Cook Medical LLC
- Terumo Corporation
- AngioDynamics Inc.
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Bristol-Myers Squibb Company
- AstraZeneca plc
- Novartis AG
- Eli Lilly and Company
- Gilead Sciences Inc.
- Regeneron Pharmaceuticals Inc.
- Incyte Corporation
- Seattle Genetics Inc.
For more information about this report visit https://www.researchandmarkets.com/r/v2xxyb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
